文献速递真实世界研究与卫生经济流行病学与生物统计

腹部手术中机会性输卵管切除术预防卵巢癌的成本效果模型研究

Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study.
PubMed 文献 · PLoS Med · 2025-01-30

该模型模拟德国20–85岁女性,比较四种机会性输卵管切除术(OS)策略与不实施OS。策略I在全部适宜腹部手术中实施OS,可预防15.34%卵巢癌病例,ICER为每获得质量调整生命年(QALY)节省8685.50欧元,人均终身节省20.89欧元。

要点

  • 策略I(全部适宜腹部手术中OS)预防卵巢癌15.34%,ICER为每QALY节省8685.50欧元。
  • 策略III仅在全子宫切除或绝育时OS,预防卵巢癌5.48%,ICER为每QALY节省4511.86欧元。
  • 癌症风险降低幅度<27%(HR>0.73)时,策略I可预防病例降至4.07%。

核心结论

  • 基于本模型,在全部适宜腹部手术中跨学科实施OS可能有助于预防卵巢癌并降低医疗费用,且更广泛实施策略在临床和经济效果及参数变化稳健性上表现更优。

研究设计与样本

  • 本研究为成本效果建模分析,构建代表所有相关健康状态的状态转移模型,转移概率基于德国2019年住院病例数。
  • 模拟20–85岁女性,按年周期循环,模拟1,200,000名个体。
  • 比较四种策略:I在全部适宜腹部手术中OS;II仅在适宜妇科手术中OS;III仅在全子宫切除或绝育时OS;IV不实施OS。

主要发现

  • 策略I的适宜干预量为286,736例,是策略III(82,319例)的3.5倍。
  • 以策略IV为参照,卵巢癌病例在策略I减少15.34%,策略II减少9.78%,策略III减少5.48%。
  • 设定OS成本为216.19欧元时,策略I的ICER为每QALY节省8685.50欧元,策略II为每QALY节省8270.55欧元,策略III为每QALY节省4511.86欧元。
  • 若风险降低<27%(HR>0.73),可预防卵巢癌病例降至策略I vs IV 4.07%、策略II vs IV 1.90%、策略III vs IV 0.37%。
  • 所有测试参数范围内,策略I和II的ICER低于2倍人均国内生产总值(GDP/C)(德国2022年为94,366欧元/QALY),但策略III在风险降低<35%(HR>0.65)时超过该阈值。

临床怎么用

  • 作者认为,基于本模型,在全部适宜腹部手术中跨学科实施OS可能有助于预防卵巢癌并降低医疗费用。

局限性

  • 本研究仅限于住院部门数据和直接医疗成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is indication that the fallopian tubes might be involved in ovarian cancer pathogenesis and their removal reduces cancer risk. Hence, bilateral salpingectomy during hysterectomy or sterilization, so called opportunistic salpingectomy (OS), is gaining wide acceptance as a preventive strategy. Recently, it was discussed whether implementation of OS at other gynecologic surgery, e.g., cesarean section, endometriosis excision or myomectomy and even at non-gynecologic abdominal surgery such as cholecystectomy or appendectomy for women with completed family could be feasible. This modeling analysis evaluated the clinical and economic potential of OS at gynecologic and abdominal surgeries. METHODS AND FINDINGS: A state transition model representing all relevant health states (healthy, healthy with hysterectomy or tubal ligation, healthy with other gynecologic or non-gynecologic abdominal surgery, healthy with hysterectomy and salpingectomy, healthy with salpingectomy, healthy with hysterectomy and salpingo-oophorectomy, ovarian cancer and death) was developed and informed with transition probabilities based on inpatient case numbers in Germany (2019). Outcomes for women aged 20-85 years were simulated over annual cycles with 1,200,000 million individuals. We compared four strategies: (I) OS at any suitable abdominal surgery, (II) OS only at any suitable gynecologic surgery, (III) OS only at hysterectomy or sterilization, and (IV) no implementation of OS. Primary outcome measures were prevented ovarian cancer cases and deaths as well as the incremental cost-effectiveness ratio (ICER). Volume of eligible interventions in strategy I was 3.5 times greater than in strategy III (286,736 versus 82,319). With strategy IV as reference, ovarian cancer cases were reduced by 15.34% in strategy I, 9.78% in II, and 5.48% in III. Setting costs for OS to €216.19 (calculated from average OS duration and operating room minute costs), implementation of OS would lead to healthcare cost savings as indicated by an ICER of €-8,685.50 per quality-adjusted life year (QALY) gained for strategy I, €-8,270.55/QALY for II, and €-4,511.86/QALY for III. Sensitivity analyses demonstrated stable results over a wide range of input parameters with strategy I being the superior approach in the majority of simulations. However, the extent of cancer risk reduction after OS appeared as the critical factor for effectiveness. Preventable ovarian cancer cases dropped to 4.07% (I versus IV), 1.90% (II versus IV), and 0.37% (III versus IV) if risk reduction would be <27% (hazard ratio [HR] > 0.73). ICER of strategies I and II was lower than the 2× gross domestic product per capita (GDP/C) (€94,366/QALY, Germany 2022) within the range of all tested parameters, but strategy III exceeded this threshold in case-risk reduction was <35% (HR > 0.65). The study is limited to data from the inpatient sector and direct medical costs. CONCLUSIONS: Based on our model, interdisciplinary implementation of OS in any suitable abdominal surgeries could contribute to prevention of ovarian cancer and reduction of healthcare costs. The broader implementation approach demonstrated substantially better clinical and economic effectiveness and higher robustness with parameter variation. Based on a lifetime cost saving of €20.89 per capita if OS was performed at any suitable abdominal surgery, the estimated total healthcare cost savings in Germany could be more than €10 million annually.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Kather A, Arefian H, Schneider C, et al. Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study. PLoS Med. 2025. PMID: 39883621. doi:10.1371/journal.pmed.1004514

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。